Chugai Pharmaceutical
All
Newsflash
Article
-
Roche-owned Chugai Pharma to boost in-house output with 50% capex increase
The Japanese drugmaker plans to invest around 100 billion yen ($635 million) annually in facilities and equipment by 2028, aiming to reduce outsourcing and cut costs.
-
Roche-owned Chugai Pharma to boost in-house output with 50% capex increase
The Japanese drugmaker plans to invest around 100 billion yen ($635 million) annually in facilities and equipment by 2028, aiming to reduce outsourcing and cut costs.
- No data
Chugai Pharmaceutical
Svmuu provides news and information related to Chugai Pharmaceutical, as well as real-time data on Chugai Pharmaceutical. We provide in-depth analysis and interpretation of the latest Chugai Pharmaceutical developments, helping investors stay informed about Chugai Pharmaceutical policy updates. Svmuu is your essential tool for keeping up with the latest Chugai Pharmaceutical trends! Here, we’ll join you in keeping a close eye on Chugai Pharmaceutical news and use a clear macro perspective to make sense of the uncertain future of crypto.
24H Trending
-
1
Ethereum Classic (ETC) Future Outlook and Highlights Analysis: PoW, Fixed Supply, and 2026 Halving Upgrade
-
2
What is BNB? An Analysis of Binance’s Exchange Token BNB Positioning and Value Logic
-
3
Why should we pay attention to Ethereum?
-
4
What is Bee Network (BEE)? Trading Channels and Risk Analysis
-
5
Where can Audius (AUDIO) be bought and sold?
-
6
Top 10 Global Crypto Trading Apps: Ranking and Evaluation Metrics Breakdown
-
7
How to Buy Ethereum? Beginner's Guide and Exchange Selection
-
8
The Evolution of Ethereum's Consensus Mechanism: The Journey and Impact from Proof of Work to Proof of Stake
-
9
A Comprehensive Guide to Stellar and XRP: Positioning, Ecosystems, and Future Outlook
-
10
How to buy, sell, and trade Hera Finance (HERA)? Which exchanges is it listed on?
Markets Today
Recommended Reading





